Basic assessment for all should include screening for pathogenic mutations in MECP2-gene and:• PTEN-gene analysis if concurrent macrocephaly;• Males: Fragile X testing;• Females: Fragile X if indicated by family history and/or phenotype. Here, PTEN is linked to Macrocephaly.